Pharmaceutical product permissions

A searchable record of what Walter is equipped to evaluate.

Explore compositions across oral solids, oral liquids, sterile injectables, topical formats and selected specialist presentations. Use the catalogue to begin a technical and commercial discussion—not as a substitute for written facility-specific confirmation.

5,500Distinct records
21Dosage forms
407Sterile injectable records
17Therapeutic indexes

Built for portfolio teams

Move from a molecule search to a focused feasibility conversation.

The catalogue brings together composition, strength, pharmacological class, dosage form, manufacturing stream, BCS class and documented regulatory references. It also incorporates products listed in Walter’s March 2025 Injectables Manufacturing Profile. Therapeutic and pharmacological classes are practical navigation labels; final indication, regulatory position and site suitability are confirmed product by product.

Search the catalogue

Selected catalogue briefs

Explore a composition for your manufacturing brief.

Browse selected compositions by dosage form, then share the required strength, pack, quantities and target market for a product-specific feasibility review.

Search the full catalogue
Browse 26 selected composition briefs

Therapeutic index

Begin with the treatment area.

Each composition is assigned to one practical primary area for navigation. Combination products may span more than one clinical use and remain subject to product-specific review.

Searchable permissions catalogue

Find a composition, dosage form or capability route.

5,500distinct permission records

Loading full catalogue search…
Therapeutic area
Dosage-form family
Specific dosage form
Pharmacological class
Manufacturing stream
BCS classification
Confirmed CDSCO category
Drugs Rules status

24 records shown

Respiratory & allergyPRM 2592
Dosage formTablets
Oral

Acebrophylline 200 mg (SR), Desloratadine 5 mg, Montelukast 10 mg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
H1 antihistamine + Leukotriene receptor antagonist + Xanthine bronchodilator
Manufacturing stream
Non-beta-lactam
BCS class
Class II (mixed)
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Respiratory & allergyPRM 2593
Dosage formTablets
Oral

Acebrophylline 200 mg (SR), Fexofenadine 120 mg, Montelukast 10 mg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
H1 antihistamine + Leukotriene receptor antagonist + Xanthine bronchodilator
Manufacturing stream
Non-beta-lactam
BCS class
Class II (mixed)
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Respiratory & allergyPRM 4628
Dosage formHard-gelatin capsules
Oral

Acrivastine 8 mg

Route
Oral
Formulation type
Hard-capsule oral solid
Pharmacological class
H1 antihistamine
Manufacturing stream
Non-beta-lactam
BCS class
Class III
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Ophthalmology & ENTPRM 5677
Dosage formEye drops
Ophthalmic

Alcaftadine 0.25% w/v

Route
Ophthalmic
Formulation type
Ophthalmic liquid drops
Pharmacological class
H1 antihistamine
Manufacturing stream
Non-beta-lactam
BCS class
N/A — Local
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Ophthalmology & ENTPRM 5678
Dosage formEye drops
Ophthalmic

Alcaftadine 0.25% w/v, Ketorolac Tromethamine 0.4% w/v

Route
Ophthalmic
Formulation type
Ophthalmic liquid drops
Pharmacological class
H1 antihistamine + NSAID analgesic
Manufacturing stream
Non-beta-lactam
BCS class
N/A — Local
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Respiratory & allergyPRM 5181
Dosage formSyrup
Oral

Alcohol 0.2625 ml, Alcohol Content 5% v/v, Ammonium Chloride 0.138 gm, Diphenhydramine Hcl 14.08 mg, Menthol 1.14 mg, Sodium Citrate 57.03 mg / 5 ml

Route
Oral
Formulation type
Oral liquid syrup
Pharmacological class
Expectorant + H1 antihistamine
Manufacturing stream
Non-beta-lactam
BCS class
N/A — Oral Liquid
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Respiratory & allergyPRM 5185
Dosage formSyrup
Oral

Ambroxol 15 mg, Chlorpheniramine Maleate 2 mg, Dextromethorphan Hbr 10 mg, Menthol 1.5 mg, Phenylephrine 5 mg / 5 ml

Route
Oral
Formulation type
Oral liquid syrup
Pharmacological class
Adrenergic decongestant + Antitussive + H1 antihistamine + Mucolytic
Manufacturing stream
Non-beta-lactam
BCS class
N/A — Oral Liquid
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Respiratory & allergyPRM 5442
Dosage formOral suspension
Oral

Ambroxol 15 mg, Chlorpheniramine Maleate 2 mg, Paracetamol 125 mg, Phenylephrine 5 mg / 5 ml

Route
Oral
Formulation type
Oral liquid suspension
Pharmacological class
Adrenergic decongestant + H1 antihistamine + Mucolytic + Non-opioid analgesic / antipyretic
Manufacturing stream
Non-beta-lactam
BCS class
N/A — Oral Liquid
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Respiratory & allergyPRM 5186
Dosage formSyrup
Oral

Ambroxol 30 mg, Cetirizine 10 mg / 5 ml

Route
Oral
Formulation type
Oral liquid syrup
Pharmacological class
H1 antihistamine + Mucolytic
Manufacturing stream
Non-beta-lactam
BCS class
N/A — Oral Liquid
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Respiratory & allergyPRM 2691
Dosage formTablets
Oral

Ambroxol 30 mg, Olopatadine 5 mg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
H1 antihistamine + Mucolytic
Manufacturing stream
Non-beta-lactam
BCS class
Class III (mixed)
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Respiratory & allergyPRM 2693
Dosage formTablets
Oral

Ambroxol 60 mg, Levocetirizine 2.5 mg, Paracetamol 500 mg, Phenylephrine 5 mg Uncoated

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Adrenergic decongestant + H1 antihistamine + Mucolytic + Non-opioid analgesic / antipyretic
Manufacturing stream
Non-beta-lactam
BCS class
Class I
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Respiratory & allergyPRM 2694
Dosage formTablets
Oral

Ambroxol 60 mg, Levocetirizine 5 mg, Phenylephrine 5 mg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
Adrenergic decongestant + H1 antihistamine + Mucolytic
Manufacturing stream
Non-beta-lactam
BCS class
Class I
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Respiratory & allergyPRM 2697
Dosage formTablets
Oral

Ambroxol 75 mg, Cetirizine 10 mg (SR)

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
H1 antihistamine + Mucolytic
Manufacturing stream
Non-beta-lactam
BCS class
Class III (mixed)
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Respiratory & allergyPRM 4677
Dosage formHard-gelatin capsules
Oral

Ambroxol 75 mg, Levocetirizine 5 mg (SR)

Route
Oral
Formulation type
Hard-capsule oral solid
Pharmacological class
H1 antihistamine + Mucolytic
Manufacturing stream
Non-beta-lactam
BCS class
Class I
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Respiratory & allergyPRM 5193
Dosage formSyrup
Oral

Ambroxol Hcl 15 mg, Levocetirizine DiHcl 2.5 mg, Menthol 1 mg / 5 ml

Route
Oral
Formulation type
Oral liquid syrup
Pharmacological class
H1 antihistamine + Mucolytic
Manufacturing stream
Non-beta-lactam
BCS class
N/A — Oral Liquid
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Respiratory & allergyPRM 5196
Dosage formSyrup
Oral

Ambroxol Hcl 30 mg, Cetirizine DiHcl 2.5 mg / 5 ml

Route
Oral
Formulation type
Oral liquid syrup
Pharmacological class
H1 antihistamine + Mucolytic
Manufacturing stream
Non-beta-lactam
BCS class
N/A — Oral Liquid
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Respiratory & allergyPRM 5201
Dosage formSyrup
Oral

Ambroxol Hcl 30 mg, Guaifenesin 50 mg, Levocetirizine Hcl 2.5 mg / 5 ml

Route
Oral
Formulation type
Oral liquid syrup
Pharmacological class
Expectorant + H1 antihistamine + Mucolytic
Manufacturing stream
Non-beta-lactam
BCS class
N/A — Oral Liquid
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Respiratory & allergyPRM 2703
Dosage formTablets
Oral

Ambroxol Hcl 60 mg, Cetirizine Hcl 5 mg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
H1 antihistamine + Mucolytic
Manufacturing stream
Non-beta-lactam
BCS class
Class III (mixed)
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Respiratory & allergyPRM 5206
Dosage formSyrup
Oral

Ambroxol Hcl 60 mg, Cetirizine Hcl 5 mg / 5 ml

Route
Oral
Formulation type
Oral liquid syrup
Pharmacological class
H1 antihistamine + Mucolytic
Manufacturing stream
Non-beta-lactam
BCS class
N/A — Oral Liquid
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Respiratory & allergyPRM 2704
Dosage formTablets
Oral

Ambroxol Hcl 60 mg, Loratadine 5 mg

Route
Oral
Formulation type
Solid oral tablet
Pharmacological class
H1 antihistamine + Mucolytic
Manufacturing stream
Non-beta-lactam
BCS class
Class II (mixed)
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Respiratory & allergyPRM 4678
Dosage formHard-gelatin capsules
Oral

Ambroxol Hcl 75 mg, Desloratadine 5 mg (SR)

Route
Oral
Formulation type
Hard-capsule oral solid
Pharmacological class
H1 antihistamine + Mucolytic
Manufacturing stream
Non-beta-lactam
BCS class
Class II (mixed)
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Respiratory & allergyPRM 4679
Dosage formHard-gelatin capsules
Oral

Ambroxol Hcl 75 mg, Levocetirizine Hcl 5 mg, Pseudoephedrine Hcl 120 mg (SR)

Route
Oral
Formulation type
Hard-capsule oral solid
Pharmacological class
Adrenergic decongestant + H1 antihistamine + Mucolytic
Manufacturing stream
Non-beta-lactam
BCS class
Class I
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Respiratory & allergyPRM 5209
Dosage formSyrup
Oral

Ammonium Chloride 100 mg, Diphenhydramine Hcl 10 mg, Sodium Citrate 60 mg / 5 ml

Route
Oral
Formulation type
Oral liquid syrup
Pharmacological class
Expectorant + H1 antihistamine
Manufacturing stream
Non-beta-lactam
BCS class
N/A — Oral Liquid
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Respiratory & allergyPRM 5210
Dosage formSyrup
Oral

Ammonium Chloride 100 mg, Diphenhydramine Hcl 12.5 mg, Menthol 2 mg, Sodium Citrate 50 mg / 5 ml

Route
Oral
Formulation type
Oral liquid syrup
Pharmacological class
Expectorant + H1 antihistamine
Manufacturing stream
Non-beta-lactam
BCS class
N/A — Oral Liquid
Regulatory pathwayProduct-specific review

Applicable central and/or state licensing requirements are confirmed against the composition, strength, dosage form and manufacturing unit before commercial commitment.

Explore the product catalogue

Browse product pages by therapeutic area.

Browse compositions, strengths and dosage forms for third-party and contract manufacturing enquiries. Each product page includes its catalogue specification, manufacturing and packaging considerations, and a product-specific enquiry link. Confirm the applicable unit, documents and commercial terms with Walter.

How to read this catalogue

Permission is a starting point—not a supply commitment.

01

Therapeutic index

Primary areas provide buyer-friendly navigation. Combination products may reasonably sit across several clinical categories.

02

Facility confirmation

Current licence scope, site allocation, equipment fit and applicable segregation requirements are checked before commitment.

03

Product feasibility

Formula, strength, presentation, pack, target market, testing requirements and commercial scale are assessed together.

04

Responsible use

This B2B catalogue is not prescribing information, patient guidance or a representation that every composition is currently available for sale.

Start the conversation

Found a composition worth discussing?

Use the enquiry link on any record to carry its composition and dosage form into your manufacturing brief.

Request a quote
Quick chat on WhatsAppLet’s discuss your product